abstract |
(57) Abstract: The present invention provides a compound of the general formula (I) for reducing blood glucose and / or inhibiting the secretion, circulation or effect of CGRP or amylin-like insulin antagonist peptide. The use of the compound of Thus, the compounds can be used for the treatment of NIDDM (non-insulin dependent diabetes mellitus) or insulin resistance in aging. |